Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Trichohyalin may trigger the immune response causing alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Recognizing CVG can help diagnose systemic amyloidosis early.

Removing the liver tumor improved the patient's skin condition and hair growth.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Tissue-specific variation in mutant load complicates genetic counseling and prenatal diagnosis.

SLHA can be hard to diagnose and needs teamwork between specialists.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Monoclonal antibodies are often linked to alopecia areata cases.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Alopecia areata involves immune response and gene changes affecting hair loss.

Waldenstrom’s Macroglobulinaemia can mimic multiple myeloma, so accurate diagnosis is crucial.